NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 356 filers reported holding NEKTAR THERAPEUTICS in Q1 2019. The put-call ratio across all filers is 1.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $376,000 | +0.5% | 10,572 | -5.0% | 0.00% | 0.0% |
| Q1 2019 | $374,000 | -47.1% | 11,128 | -48.3% | 0.00% | -40.0% |
| Q4 2018 | $707,000 | -46.3% | 21,511 | -0.4% | 0.01% | -44.4% |
| Q3 2018 | $1,317,000 | +490.6% | 21,602 | +931.6% | 0.01% | +350.0% |
| Q1 2018 | $223,000 | -94.0% | 2,094 | -98.6% | 0.00% | -92.3% |
| Q3 2017 | $3,695,000 | +35.0% | 153,958 | +9.9% | 0.03% | +36.8% |
| Q2 2017 | $2,738,000 | – | 140,043 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
| First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
| Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
| BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
| Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
| Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
| Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
| TOBAM | 640,547 | $21,522,000 | 1.09% |
| Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |